Vandetanib (Zactima) received full approval from the US Food and Drug Administration (FDA) for patients with nonresectable or metastatic medullary thyroid cancer (MTC). Vandetanib was initially approved under the FDA’s orphan drug program, becoming the first medical treatment for MTC.
A new report states that in spite of declining death rates, cancer has exceeded heart disease as the leading cause of death among Hispanics in the US. According to American Cancer Society researchers, 29,935 people of Hispanic origin in the US died of cancer in 2009, compared with 29,611 deaths from heart disease that same year.
In 2012, an estimated 112,800 new cases of cancer will be diagnosed and 33,200 cancer deaths will occur among Hispanics, the largest and fastest growing major demographic group in the US.
University of Utah School of Medicine researchers have found compelling evidence that Parkinson’s disease (PD) is associated with an increased risk of prostate cancer and melanoma. Research analysis shows this increased cancer risk also extends to close and distant relatives of individuals with PD, a progressive neurologic condition that leads to tremors and difficulty with walking, movement, and coordination. This is the first time that an increased risk of prostate cancer has been reported in PD.
Women with type 2 diabetes are nearly 30% more likely to get breast cancer, according to a comprehensive review of 40 separate studies examining the potential link between breast cancer and diabetes. The analysis, by researchers at the International Prevention Research Institute (i-PRI), Lyon, is published in the British Journal of Cancer.
To sign up for our newsletter or print publications, please enter your contact information below.
